Catherine with N95 shipment from China

Intuitive Foundation and Fosun Pharma Help Fight COVID-19

N95 IntuFosunDonated Masks to HubeiReciprocating donations of protective N95 masks and tests highlight cooperation

The Intuitive Foundation, an independent philanthropic entity dedicated to helping people globally, and Fosun Pharma, the Shanghai, China-based pharmaceutical company, have exchanged donated equipment aimed at helping healthcare professionals in both countries battle COVID-19.

As the pandemic hit its peak in China early in 2020, the Intuitive Foundation coordinated donations for 4,800 N95 respirator masks to Huanggang Central Hospital, located in China’s Hubei province. Employees of Intuitive made direct donations through Bright Funds – an entity that helps match and coordinate philanthropic donations – to help purchase over $10,000 worth of medical supplies for other rural hospitals in the province through alumni groups with deep personal ties in the area.

After the pandemic began to flatten in China – and to spike in the U.S. – Fosun Pharma reciprocated the goodwill by sourcing 50,000 N95 respirator masks for the Intuitive Foundation to provide personal protective equipment (PPE) to healthcare facilities that needed it most.

In addition, Fosun Pharma will donate 5,000 Polymerase Chain Reaction (PCR) tests for detecting the COVID-19 virus, and the Intuitive Foundation will work with its partners to determine a facility where testing needs are high to receive these test kits.

The Fosun COVID-19 RT-PCR Detection Kit uses PCR technology to detect the virus’ nucleic acid and provides accurate diagnostic results. The U.S. Food and Drug Administration granted its Emergency Use Authorization for the Fosun test on April 17.

“By working together, we’ve helped make a difference in each country’s response to this pandemic at the moments we each needed help the most,” said Catherine Mohr, president of the Intuitive Foundation. “It’s been an honor to be the recipient of Fosun Pharma’s generosity and we hope to continue finding ways to build upon this cooperation.”

“We are grateful for the generous humanitarian support from Intuitive Foundation and people around the world when COVID-19 hit China,” said Lily Zou, CEO of Fosun Pharma USA.  “Now we are honored and privileged to collaborate with the Intuitive Foundation again, leveraging each organization’s strength, to fight against this pandemic in the U.S.”

Intuitive Surgical and Fosun Pharma operate a joint venture in China to sell and support robotic-assisted technologies and services. The Intuitive Foundation is an independent entity from Intuitive Surgical.

About the Intuitive Foundation

Created in 2018 through a gift from Intuitive Surgical, the Intuitive Foundation is dedicated to reducing the global burden of disease and suffering through philanthropy, research and education aimed at better outcomes for patients everywhere. Through grants and other funding activities, the Foundation promotes global health, and supports research in the fields of science, medicine, technology, engineering, and math. In addition, the Foundation works to advance educational organizations and support related healthcare educational programs, training, and fellowships, and to provide direct disaster relief.

For more information, please visit the company’s website at www.intuitive-foundation.org.

About Fosun Pharma

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”; stock code: 600196.SH, 02196.HK) is a leading healthcare group in China. Fosun Pharma has built strong roots in China and developed a global operation strategy with business that spans the entire healthcare value chain, which is centered on pharmaceutical manufacturing and R&D as its largest segments, with additional presence in medical devices and diagnostics, healthcare services, pharmaceutical distribution and retail.

With R&D innovation as core driving factor, Fosun Pharma continues to optimize its pharmaceutical operations across both innovative and generic drugs. The company has established international R&D centers for excellence in areas such as innovative small molecule drugs, high-value generic drugs, biologics, and cell-therapy.

Under guidance of our 4IN strategy (Innovation, Internationalization, Integration and Intelligentization), Fosun Pharma follows the brand concept of Innovation for Good Health and strives to be a leading enterprise in the global pharmaceutical and healthcare markets.

For more information on the company, please visit our official website: www.fosunpharma.com